HIV Gene Therapy
Virion-Targeted Viral Inactivation Weakens HIV
Published in AIDS Weekly, February 19th, 1996
Although twisty, elusive and capable of mutating quickly, the HIV infection cycle actually provides multiple opportunities for therapeutic intervention.
G. Pignac-Kobinger et al. submitted data at the 3rd Conference on Retroviruses and Opportunistic Infections, held January 28 - February 1, 1996, in Washington, D.C., which suggested that virion-targeted viral inactivation may provide a unique opportunity to interfere with HIV viral replication.
"In this strategy, a deleterious amino acid sequence is fused to a virion-associated component to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (1996-02-19)
More Articles from AIDS Weekly
- Conference Coverage (Retrovirus)
Radical Change in AIDS Therapy - Conference Coverage (Retrovirus)
AIDS Vaccine Data Called "Unpleasant, Unpalatable" - Conference Coverage (Retrovirus)
Cell Genesys Gene Therapy Safe in Early Trial - Conference Coverage (Retrovirus)
Chemokines Can Both Suppress and Activate HIV - Conference Coverage (Retrovirus)
HIV Infected Subjects Dampen Hopes for Chiron, Genentech Vaccines - Conference Coverage (Retrovirus)
New Drug Clinically Active Against Both HIV and CMV - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
